Torrent-JB Pharma: Strategic Fit, Overpriced Acquisition? Torrent Pharma’s mega JB Chemicals acquisition signals bold ambition. But will its premium bet on scale and diversification pay off or prove costly?

Torrent Pharma’s ₹256.89B JB Chemicals buy is bold—but at 6.7x sales, is it too rich? It may add scale, but risks are real: high price, integration hurdles, and modest rank shift. Strategic or stretched?

Read Dev Chandrasekhar’s article 👇

#TorrentPharma #JBPharma #PharmaPlay #ValuationDebate